Product Information
MENEST 1.25 MG TABLET is a brand (anda) product labeled by Pfizer Inc., priced at $3.5806 per EA under NDC 61570007401. Its NADAC has been published 315 times since Nov 28, 2013.
FDA first approved this application before 1982.
Strength
1.25 mg/1
Manufacturer
Pfizer Inc.NDC
61570007401
Classification
Brand (ANDA)
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
ESTROGENS, ESTERIFIEDApproval Type
Generic (ANDA)
FDA Application
ANDA084950FDA Approved
Before 1982
On Market Since
9/28/1977
Price Statistics
The NADAC for MENEST 1.25 MG TABLET has been published 315 times since Nov 28, 2013, and over the history we have for it it has risen 115.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5806 per EA |
|---|---|
| All-time high | $3.5806 (Apr 29, 2026) |
| All-time low | $1.6615 (Nov 28, 2013) |
| 52-week high | $3.5806 |
| 52-week low | $3.5806 |
| Median price | $2.5582 |
| Average price | $2.6910 |
| Largest weekly change | +20.0% (Jan 6, 2016) |
| Weeks tracked | 315 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
+8.4%
5Y
+8.4%
All
+115.5%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the esterified estrogens market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
esterified estrogens market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MENEST 1.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MENEST 1.25 MG TABLET, manufactured by Pfizer Inc., is $3.5806 per EA (NDC 61570007401), effective Apr 29, 2026.
How has the price of MENEST 1.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for MENEST 1.25 MG TABLET has risen 115.5%. It has been tracked across 315 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MENEST 1.25 MG TABLET?
Since Nov 28, 2013, the NADAC for MENEST 1.25 MG TABLET has ranged from a low of $1.6615 (Nov 28, 2013) to a high of $3.5806 (Apr 29, 2026), with a median of $2.5582 per EA.
Are there cheaper alternatives to MENEST 1.25 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MENEST 1.25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MENEST 1.25 MG TABLET?
MENEST 1.25 MG TABLET (NDC 61570007401) is labeled by Pfizer Inc., and CMS classifies it as a brand (anda) product.